These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5071255)

  • 1. Investigation on steroids. XII. Metabolites of furazabol (17 -hydroxy-17 -methyl-5 -androstano(2,3-c)furazan) administered to rats.
    Takegoshi T; Tachizawa H; Ota G
    Chem Pharm Bull (Tokyo); 1972 Jun; 20(6):1243-59. PubMed ID: 5071255
    [No Abstract]   [Full Text] [Related]  

  • 2. Some non-hormonal properties of 17 -hydroxy-17 -methyl-5 -androstano(2,3-c)furazan (furazabol).
    Onodera T; Hashizume T; Kasahara A
    Chem Pharm Bull (Tokyo); 1973 Jan; 21(1):21-4. PubMed ID: 4711514
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigations on steroids. X. Pharmacological studies. (4). Conversion of 17 beta-hydroxy-5alpha-androstano[2,3-c]furazan into 17-oxo compound by rat liver in vitro.
    Kasahara A
    Chem Pharm Bull (Tokyo); 1968 Aug; 16(8):1460-5. PubMed ID: 5708249
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic effects of furazabol, (17-beta-hydroxy-17-alpha-methyl-5-alpha-androstane [2, 3-c] furazan, on experimental atherosclerosis in rabbits].
    Onodera T; Kasahara A; Ishihara M; Ogawa H; Oshima Y
    Nihon Yakurigaku Zasshi; 1970 Jul; 66(4):458-69. PubMed ID: 5531414
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metabolism of steroid drugs. II. Isolation and identification of metabolites of 4-chlor-17 alpha-methyl-17 beta-hydroxy-1,4-androstadien-3-one].
    Schubert K; Wehrberger K
    Endokrinologie; 1970; 55(5):257-69. PubMed ID: 5439560
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigations on steroids. V. Pharmacological studies. (1). Anabolic and androgenic activities of 17beta-hydroxy-17alpha-methyl-5alpha-androstano[2,3-c]furazan (androfurazanol), a new active anabolic steroid.
    Kasahara A; Onodera T; Mogi M; Oshima Y; Shimizu M
    Chem Pharm Bull (Tokyo); 1965 Dec; 13(12):1460-9. PubMed ID: 5866245
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of fibrinolytic and thrombolytic potential in the rat by treatment with an anabolic steroid, furazabol.
    Kumada T; Abiko Y
    Thromb Haemost; 1976 Nov; 36(2):451-64. PubMed ID: 1036845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on steroids. VI. Pharmacological studies. (2). Endocrinological properties and acute toxicity of 17-beta-hydroxy-17-alpha-methyl-5-alpha-androstano[2,3-c]furazan (androfurazanol).
    Kasahara A; Onodera T; Tachizawa H; Oshima Y; Shimizu M
    Chem Pharm Bull (Tokyo); 1966 Mar; 14(3):285-92. PubMed ID: 5908757
    [No Abstract]   [Full Text] [Related]  

  • 9. 17-alpha-methyl-17-beta-hydroxy-5-alpha-androstano[2,3-c]furazan (androfurazanol), a new active anabolic steroid.
    Shimizu M; Ohta G; Ueno K; Takegoshi T; Oshima Y; Kasahara A; Onodera T; Mogi M; Tachizawa H
    Chem Pharm Bull (Tokyo); 1965 Jul; 13(7):895-7. PubMed ID: 5867819
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of fibrinolytic and thrombolytic potential in the rat by an anabolic steroid, furazabol.
    Abiko Y; Kumada T
    Thromb Res; 1976 May; 8(2 suppl):107-14. PubMed ID: 936070
    [No Abstract]   [Full Text] [Related]  

  • 11. Excretion study of furazabol, an anabolic steroid, in human urine.
    Kim T; Suh JW; Ryu JC; Chung BC; Park J
    J Chromatogr B Biomed Appl; 1996 Dec; 687(1):79-83. PubMed ID: 9001955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations on steroids. IX. Pharmacological studies. (3). Myotrophic and androgenic activities of 17beta-hydroxy-5alpha-androstano-[2,3-c]furazan and its derivatives.
    Kasahara A; Onodera T; Oshima Y; Shimizu M
    Chem Pharm Bull (Tokyo); 1968 Aug; 16(8):1456-9. PubMed ID: 5708248
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influences of testosterone, progesterone and furazabol, an anabolic steroid, on the cholesterol-shifting response to estrone].
    Ozawa H; Onodera T; Nakamura I
    Yakugaku Zasshi; 1972 Mar; 92(3):316-21. PubMed ID: 5065552
    [No Abstract]   [Full Text] [Related]  

  • 14. Anabolic and androgenic activity of 19-norandrostenedione after oral and subcutaneous administration--analysis of side effects and metabolism.
    Parr MK; Laudenbach-Leschowsky U; Höfer N; Schänzer W; Diel P
    Toxicol Lett; 2009 Jul; 188(2):137-41. PubMed ID: 19446246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the in vivo biosynthesis of C 19 - 16 -steroids in healthy men.
    Brooksbank BW; Wilson DA
    Steroidologia; 1970; 1(2):113-28. PubMed ID: 5520686
    [No Abstract]   [Full Text] [Related]  

  • 16. [Do anabolic steroids protect bone marrow during cytostatic therapy?].
    Kopera H
    Med Klin; 1980 Jul; 75(15):539-43. PubMed ID: 7001201
    [No Abstract]   [Full Text] [Related]  

  • 17. [Modification of protein metabolism by anabolic steroids in various protein diets in patients with chronic liver diseases].
    Blahníková L; Horký J
    Cesk Gastroenterol Vyz; 1973 Apr; 27(3):121-7. PubMed ID: 4702017
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic studies of oxyguno in horses.
    Wong AS; Ho EN; Wan TS; Lam KK; Stewart BD
    Anal Chim Acta; 2015 Sep; 891():190-202. PubMed ID: 26388378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of furazabol metabolite.
    Gradeen CY; Chan SC; Przybylski PS
    J Anal Toxicol; 1990; 14(2):120-2. PubMed ID: 2325377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Steroids and the skin. VII. Excretion of C19 and C18 steroids in feces and urine following administration von (7 alpha-3H) 3 beta-hydroxy-5-androsterone-17-one(35S)sulfate to a patient with psoriasis vulgaris].
    Bregenzer M; Morsches B; Holzmann H; Oertel G
    Hoppe Seylers Z Physiol Chem; 1971 Apr; 352(4):549-54. PubMed ID: 5559164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.